EBR Systems Achieves Milestone with Tenth WiSE System Implant

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) has provided an announcement.

EBR Systems, Inc. has achieved a significant milestone by completing the tenth commercial implant of its WiSE System in the US, marking a promising step in its pilot launch phase. This achievement, along with upcoming reimbursement schemes, positions EBR for a successful limited market release in October 2025, potentially enhancing its market presence and adoption among hospitals. The company’s strategy focuses on fewer sites with higher utilization rates, and the recent approvals for reimbursement pathways are expected to support its commercialization efforts, benefiting patients who are not well served by conventional CRT methods.

The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.25 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.

More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

Silicon Valley-based EBR Systems, Inc. is a company focused on advancing cardiac rhythm disease treatment through its innovative Wireless Stimulation Endocardially (WiSE) technology. This technology eliminates the need for traditional cardiac pacing leads, which have historically been a source of complications and reliability issues. The WiSE system is the world’s only wireless, endocardial pacing system in clinical use for stimulating the heart’s left ventricle, aiming to provide a more physiologically effective stimulation for heart failure patients requiring Cardiac Resynchronisation Therapy (CRT).

Average Trading Volume: 691,557

Technical Sentiment Signal: Sell

Learn more about EBR stock on TipRanks’ Stock Analysis page.